Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

BullFrog AI CEO Vin Singh to Participate in Panel Discussion at Pharma Partnering Summit

BullFrog AI Holdings a digital technology company using machine learning to usher in a new era of precision medicine announced that Vin Singh, Chief Executive Officer, will participate in a panel discussion titled “Best Practices and Key Considerations for Successful Deals.

Recommended: ChatGPT’s Rival has Arrived: Hugging Face Introduces Open-Source Version of ChatGPT

As a leader in the digital health space, I’m honored to join this panel and share my experiences on how to craft successful deals,” said Singh. “This event is a great opportunity for many of us invested in the ‘healthcare meets technology’ world to come together, learn from each other, and discuss best practices that lead to success.”

The Pharma Partnering Summit brings together dealmakers of leading life science companies to create a range of partnering opportunities. The Summit also provides insights on new paradigms for external innovations and disseminates knowledge through expert speakers for the best practices in industry partnerships.

Related Posts
1 of 40,753

Latest Insights: AiThority Interview with Luke Butler and Laura Plunkett, Executive Director, Startup Engagement at Comcast NBCUniversal

BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may seek to receive the therapies they need.

Latest Insights: Transforming Cybersecurity: Google Cloud Launches Generative AI Model SEC-PALM

[To share your insights with us, please write to sghosh@martechseries.com]

Comments are closed.